Bulletin 2010/35 - European Patent Office
28.12.2012 • Views
Share Embed Flag

Bulletin 2010/35 - European Patent Office

Bulletin 2010/35 - European Patent Office

Bulletin 2010/35 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

START NOW

(A61K) II.1(1)<br />

BAGUE, Séverine, F-91360 Epinay-sur Orge,<br />

FR<br />

RABINOVICH-GUILATT, Laura, 60920<br />

Kadima, IL<br />

LAMBERT, Grégory, F-92290 Chatenay<br />

Malabry, FR<br />

(74) Icosa, 142, rue de Rennes, 75006 Paris, FR<br />

(51) A61K 9/14 (11) 1 070 725 B1<br />

A61K 31/70<br />

(25) Ja (26) En<br />

(21) 99916044.3 (22) 09.04.1999<br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE<br />

(43) 24.01.2001<br />

(86) JP 1999/001907 09.04.1999<br />

(87) WO 1999/052931 1999/42 21.10.1999<br />

(30) 10.04.1998 JP 9889998<br />

(54) • SIALSÄURE-DERIVATE ENTHALTENDE<br />

FESTE DISPERSION<br />

• SOLID DISPERSION CONTAINING SIALIC<br />

ACID DERIVATIVE<br />

• DISPERSION SOLIDE CONTENANT UN<br />

DERIVE D'ACIDE SIALIQUE<br />

(73) Mitsubishi Chemical Corporation, 14-1,<br />

Shiba 4-chome, Minato-ku Tokyo 108-0014,<br />

JP<br />

(72) INAMORI, Takeshi;, Mitsubishi Chem.Corp.,<br />

Kashima-gun, Ibaraki 314-0255, JP<br />

TAKAHASHI, Chikako;, Mitsubishi Chem.<br />

Corp., Kashima-gun, Ibaraki 314-0255, JP<br />

FUJIMURA, Yoshiyuki;, Mitsubishi Chem.<br />

Corp., Yokohama-shi, Kanagawa 227-8502,<br />

JP<br />

(74) Polypatent, Postfach 40 02 43, 51410<br />

Bergisch Gladbach, DE<br />

(51) A61K 9/16 (11) 1 962 806 B1<br />

A61K 9/20 A61K 47/26<br />

A61K 33/06 A23L 1/09<br />

A23L 1/303 A23L 1/304<br />

(25) En (26) En<br />

(21) 06818154.4 (22) 07.12.2006<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

(43) 03.09.2008<br />

(86) DK 2006/000695 07.12.2006<br />

(87) WO 2007/065440 2007/24 14.06.2007<br />

(30) 07.12.2005 DK 2005017<strong>35</strong><br />

(54) • VORKOMPAKTIERTE CALCIUMHALTIGE<br />

ZUSAMMENSETZUNGEN<br />

• PRE-COMPACTED CALCIUM-CONTAINING<br />

COMPOSITIONS<br />

• COMPOSITIONS CONTENANT DU CAL-<br />

CIUM PRE-COMPACTEES<br />

(73) Nycomed Pharma AS, Drammensveien 852,<br />

1385 Asker, NO<br />

Nycomed Danmark ApS, Langebjerg 1, 4000<br />

Roskilde, DK<br />

(72) BERTELSEN, Poul Egon, DK-4000 Roskilde,<br />

DK<br />

OLSEN, Peder Mohr, DK-4970 Kirke Hyllinge,<br />

DK<br />

(74) Johansen, Marianne, Zacco Hans Bekkevolds<br />

Allé 7, 2900 Hellerup, DK<br />

(51) A61K 9/20 (11) 2 019 668 B1<br />

(25) En (26) En<br />

(21) 08726666.4 (22) 10.03.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

(43) 04.02.2009<br />

(86) US 2008/003169 10.03.2008<br />

(87) WO 2008/109170 2008/37 12.09.2008<br />

(30) 08.03.2007 US 906150 P<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(54) • PHARMAZEUTISCHE ZUSAMMENSET-<br />

ZUNG MIT CANDESARTAN-CILEXETIL<br />

• PHARMACEUTICAL COMPOSITION COM-<br />

PRISING CANDESARTAN CILEXETIL<br />

• COMPOSITION PHARMACEUTIQUE COM-<br />

PRENANT DU CANDÉSARTAN CILEXÉTIL<br />

(73) Teva Pharmaceutical Industries Ltd., 5 Basel<br />

Street P.O. Box 3190, 49131 Petah Tiqva, IL<br />

(72) LEIBOVICI, Minutza, 42312 Netanya, IL<br />

KANARI, Itamar, 442<strong>35</strong> Kefar Sava, IL<br />

FOX, Michael, 67291 Tel Aviv, IL<br />

(74) Eder, Michael, df-mp Fünf Höfe Theatinerstrasse<br />

16, 80333 München, DE<br />

A61K 9/20 → (51) A61K 9/16<br />

(51) A61K 9/28 (11) 1 928 428 B1<br />

A61K 31/5513<br />

(25) En (26) En<br />

(21) 06831860.9 (22) 27.10.2006<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

(43) 11.06.2008<br />

(86) IB 2006/003922 27.10.2006<br />

(87) WO 2007/052164 2007/19 10.05.2007<br />

(30) 03.11.2005 GB 0522474<br />

(54) • OLANZAPIN ENTHALTENDE PHARMA-<br />

ZEUTISCHE ZUSAMMENSETZUNG<br />

• A PHARMACEUTICAL FORMULATION<br />

CONTAINING OLANZAPINE<br />

• COMPOSITION PHARMACEUTIQUE<br />

CONTENANT DE L'OLANZAPINE<br />

(73) Actavis Group PTC EHF, Reykjavikurvegi 76-<br />

78, 220 Hafnarfjordur, IS<br />

(72) KRISTJANSSON, Torfi, 108 Reykjavik, IS<br />

(74) Gillard, Richard Edward, et al, Elkington and<br />

Fife LLP Thavies Inn House 3-4 Holborn<br />

Circus, London EC1N 2HA, GB<br />

A61K 31/05 → (51) A61K 31/192<br />

A61K 31/133 → (51) C07C 215/10<br />

A61K 31/137 → (51) C07D 215/22<br />

A61K 31/166 → (51) A61K 31/192<br />

(51) A61K 31/167 (11) 1 285 651 B1<br />

A61K 31/40 A61K 31/4453<br />

A61K 31/4709 A61K 31/4545<br />

A61K 31/454 A61K 31/4375<br />

A61K 31/47 A61K 31/4725<br />

C07C 233/80 C07C 237/48<br />

C07D 211/16 C07D 211/14<br />

C07D 211/18 C07D 295/1<strong>35</strong><br />

C07D 405/12 C07D 401/06<br />

C07D 417/06 C07D 401/12<br />

C07D 211/22 C07D 471/04<br />

(25) Ja (26) En<br />

(21) 01925947.2 (22) 26.04.2001<br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE TR<br />

(43) 26.02.2003<br />

(86) JP 2001/003614 26.04.2001<br />

(87) WO 2001/082925 2001/45 08.11.2001<br />

(30) 28.04.2000 JP 2000134295<br />

13.12.2000 JP 2000384897<br />

(54) • ANTAGONISTEN DES MELANIN-KON-<br />

ZENTRIERENDEN HORMONS<br />

• MELANIN CONCENTRATING HORMONE<br />

ANTAGONISTS<br />

• ANTAGONISTES DE L'HORMONE<br />

CONCENTRANT LA MELANINE<br />

(73) Takeda Pharmaceutical Company Limited, 1-<br />

1, Doshomachi 4-chome, Chuo-ku, Osaka,<br />

JP<br />

540<br />

<strong>Patent</strong>e<br />

<strong>Patent</strong>s<br />

Brevets (<strong>35</strong>/<strong>2010</strong>) 01.09.<strong>2010</strong><br />

(72) ISHIHARA, Yuji, Itami-shi, Hyogo 664-0874,<br />

JP<br />

SUZUKI, Nobuhiro, Minoo-shi, Osaka, JP<br />

TAKEKAWA, Shiro, Nishinomiya-shi, Hyogo,<br />

JP<br />

(74) Jones, Nicholas Andrew, et al, Withers &<br />

Rogers LLP Goldings House 2 Hays Lane,<br />

London SE1 2HW, GB<br />

A61K 31/17 → (51) C07C 275/24<br />

A61K 31/17 → (51) C07C 275/54<br />

(51) A61K 31/192 (11) 1 255 543 B1<br />

A61K 31/166 A61K 31/196<br />

A61K 31/05 A61K 31/28<br />

A61K 31/381 A61K 31/382<br />

A61K 31/343 A61P 17/00<br />

A61P 17/10 A61P 31/04<br />

(25) Fr (26) Fr<br />

(21) 01903998.1 (22) 30.01.2001<br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE TR<br />

(43) 13.11.2002<br />

(86) FR 2001/000280 30.01.2001<br />

(87) WO 2001/056554 2001/32 09.08.2001<br />

(30) 31.01.2000 FR 0001206<br />

(54) • VERWENDUNG VON RETINOID-TYP VER-<br />

BINDUNGEN ALS ANTIBAKTERIELLE MIT-<br />

TEL GEGEN STAPHYLOCOCCUS AUREUS<br />

• USE OF RETINOID-TYPE COMPOUNDS AS<br />

ANTIBACTERIAL AGENTS AGAINST STA-<br />

PHYLOCOCCUS AUREUS<br />

• UTILISATION DE COMPOSES DE TYPE<br />

RETINOIDES EN TANT QU'AGENTS ANTI-<br />

BACTERIENS CONTRE STAPHYLOCOCCUS<br />

AUREUS<br />

(73) GALDERMA RESEARCH & DEVELOPMENT,<br />

Les Templiers 2400 Route des Colles, 06410<br />

Biot, FR<br />

(72) VOEGEL, Johannes, F-06740 Châteauneuf/<br />

Grasse, FR<br />

CAVEY, Marie-Thérèse, F-06530 Peymeinade,<br />

FR<br />

(74) Allab, Myriam, L'OREAL D.I.P.I. 25-29 Quai<br />

Aulagnier, 92665 Asnières-sur-Seine, FR<br />

(51) A61K 31/195 (11) 1 583 525 B1<br />

A61K 31/60 A61K 31/375<br />

A61K 41/00 A61P 17/00<br />

A61P 17/06 A61P 19/00<br />

A61P 19/02 A61P 25/00<br />

(25) De (26) De<br />

(21) 03815<strong>35</strong>4.0 (22) 23.12.2003<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IT LI LU MC NL PT RO SE SI SK<br />

TR<br />

(43) 12.10.2005<br />

(86) DE 2003/004254 23.12.2003<br />

(87) WO 2004/064827 2004/32 05.08.2004<br />

(30) 17.01.2003 DE 10301917<br />

(54) • VERWENDUNG EINER KOMBINATION VON<br />

SUBSTANZEN DER PORPHYRINSYN-<br />

THESE, SALICYLATEN UND ANTIOXIDAN-<br />

TIEN BEI DER PHOTOTHERAPIE VON<br />

HAUT- UND/ODER GELENKERKRANKUN-<br />

GEN<br />

• USE OF PORPHYRIN SYNTHESIS SUB-<br />

STANCES IN COMBINATION WITH SALI-<br />

CYLATES AND ANTIOXIDANTS FOR USE<br />

IN PHOTOTHERAPY TO CURE SKIN AND<br />

ARTICULATION DISEASES<br />

• UTILISATION DE SUBSTANCES DE LA<br />

SYNTHESE DE PORPHYRINE EN COMBI-<br />

NAISON AVEC DES SALICYLATES ET DES<br />

ANTIOXIDANTS POUR L'UTILISATION EN<br />

PHOTOTHERAPIE POUR LE TRAITEMENT<br />

DE MALADIES DE LA PEAU ET DES<br />

ARTICULATIONS

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!